Sandoz ordered to pay Lundbeck over $26.3M for infringing Lexapro patent

Clayton Utz 2019-02-19 10:18 pm By Christine Caulfield | Melbourne

Please login to bookmark

Generic drug maker Sandoz must pay $26.34 million to Danish pharmacuetical giant Lundbeck and a subsidiary for infringing the Australian patent behind the blockbuster antidepressant Lexapro, a judge has found.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au